This site is intended for Healthcare Professionals only.

Search results for: novartis

FDA approves Novartis drug Cosentyx to treat hidradenitis suppurativa patients  

Phase III data showed Cosentyx can provide rapid relief from symptoms of hidradenitis suppurativa as early as Week 2 The US Food and Drug Administration...

Amgen sues Novartis in US court to block generic osteoporosis, bone cancer drugs

Amgen Inc sued Novartis AG's Sandoz in a federal court in the United States on Monday (May 1), accusing Sandoz's proposed versions of its...

Novartis scraps UK heart attack prevention trial

Novartis is halting a UK-based trial originally planned as part of a partnership with NHS England, a setback in its quest to win wider...

Operating profit set to grow as Novartis prepares to spin off its Sandoz generics business

Novartis on Wednesday (February 1) predicted that core operating income would grow in a "mid single digit" percentage range in 2023 following stagnation last year,...

Swiss competition watchdog probes Novartis over patent use

The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss...

Novartis drug combo shows promise in childhood brain cancer

An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial. In...